![Meta-analysis of non-relapse mortality post-CAR-T cells in lymphoma and myeloma](https://oncodaily.com/pub/uploads/2024/07/PhotoHandler-e1721744765978.png)
Photo of David Cordas dos Santos from connects.catalyst.harvard.edu
Jul 24, 2024, 08:12
Meta-analysis of non-relapse mortality post-CAR-T cells in lymphoma and myeloma
Nature Medicine shared on X about a paper titled “A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy” published on their journal.
Authors: David M. Cordas dos Santos, Tobias Tix, Roni Shouval, Anat Gafter-Gvili, Jean-Baptiste Alberge, Edward R. Scheffer Cliff, Sebastian Theurich, Michael von Bergwelt-Baildon, Irene M. Ghobrial, Marion Subklewe, Miguel-Angel Perales and Kai Rejeski.
“In a meta-analysis of non-relapse mortality post-CAR-T cells in patients with lymphoma and myeloma, almost 1/2 of cases were caused by pathogens and mortality estimates varied across tumor types and CAR-T cell products.”
Source: Nature Medicine/X
Anat Gafter-Gvili
cancer
CAR T-CELL
David M. Cordas dos Santos
Edward R. Scheffer Cliff
Irene M. Ghobrial
Jean-Baptiste Alberge
Kai Rejeski
lymphoma
Marion Subklewe
Michael von Bergwelt-Baildon
Miguel-Angel Perales
Myeloma
Nature Medicine
OncoDaily
Oncology
Roni Shouval
Sebastian Theurich
Tobias Tix
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023